MEDITE Cancer Diagnostics, Inc. successfully obtained Mexican Tender for 31 Stainers and First Delivery of new Manual Microtome to China
ORLANDO, Fla., Aug. 27, 2015 (SEND2PRESS NEWSWIRE) — MEDITE Cancer Diagnostics, Inc., ( OTCQB:MDIT / OTCMKTS:MDIT ) specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces its Mexican distributor, ATYDE won a public tender for delivery of 31 MEDITE tissue staining machines with a the total retail value of approximately $600,000. This is the first major sale to Mexico for MEDITE.